Market closedNon-fractional

Vaxart/VXRT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Vaxart

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Ticker

VXRT

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

South San Francisco, United States

Employees

109
Website
vaxart.com

Vaxart Metrics

BasicAdvanced
$146M
Market cap
-
P/E ratio
-$0.53
EPS
0.65
Beta
-
Dividend rate
$146M
0.65
3.137
2.637
33.317
42.58
-39.48%
-46.82%
-112.40%
11.128
2.04
2.42
-1.455
1,174.75%
-35.64%
75.28%
5.05%

What the Analysts think about Vaxart

Analyst Ratings

Majority rating from 3 analysts.
Buy

Vaxart Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,161.90% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.1M
-34.38%
Net income
-$24M
41.04%
Profit margin
-1,161.90%
114.92%

Vaxart Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.16
-$0.11
-$0.12
-$0.14
-
Expected
-$0.18
-$0.18
-$0.15
-$0.14
-$0.15
Surprise
-11.11%
-37.74%
-17.24%
0.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Vaxart stock?

Vaxart (VXRT) has a market cap of $146M as of July 06, 2024.

What is the P/E ratio for Vaxart stock?

The price to earnings (P/E) ratio for Vaxart (VXRT) stock is 0 as of July 06, 2024.

Does Vaxart stock pay dividends?

No, Vaxart (VXRT) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Vaxart dividend payment date?

Vaxart (VXRT) stock does not pay dividends to its shareholders.

What is the beta indicator for Vaxart?

Vaxart (VXRT) has a beta rating of 0.65. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Vaxart stock

Buy or sell Vaxart stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing